Shigeyoshi Iwamoto

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial

Yasuhide Yamada, Daisuke Takahari, Hiroshi Matsumoto et al. · The Lancet Oncology · 2013 · 253 citations

Medicine, Oncology, Pharmacology +12

Changing Site Distribution of Colorectal Cancer in Japan

Hideho Takada, T Ohsawa, Shigeyoshi Iwamoto et al. · Diseases of the Colon & Rectum · 2002 · 97 citations

Medicine, Oncology, Cancer Epidemiology +12

FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study

Shigeyoshi Iwamoto, Tsuyoshi Takahashi, Hiroshi Tamagawa et al. · Annals of Oncology · 2015 · 66 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Effects of fatty acids on liver metastasis of ACL‐15 rat colon cancer cells

Shigeyoshi Iwamoto, Hideto Senzaki, Yasuhiko Kiyozuka et al. · Nutrition and Cancer · 1998 · 55 citations

Medicine, Oncology, Pharmacology +13

Timing of Resection for Synchronous Liver Metastases from Colorectal Cancer

Masaki Kaibori, Shigeyoshi Iwamoto, Morihiko Ishizaki et al. · Digestive Diseases and Sciences · 2010 · 47 citations

Medicine, Oncology, Surgery +14